Squarepoint Ops »

Lexeo Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-12-31 $920k 93k 9.93

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Squarepoint Ops

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics